KALA - KALA BIO, Inc.
Previous close
7.03
0.120 1.707%
Share volume: 104
Last Updated: Thu 26 Dec 2024 07:55:17 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$6.91
0.12
1.74%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | |
| Report Date | 2022-05-16 | 2022-08-11 | 2022-11-08 | 2023-03-03 | 2023-05-09 | 2023-08-04 | |
| Total revenue | 1.372 M | 2.100 M | 420.000 K | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 775.000 K | 1.774 M | 11.000 K | 0.000 | 0.000 | 0.000 | |
| Gross profit | 597.000 K | 326.000 K | 409.000 K | 0.000 | 0.000 | 0.000 | |
| -45.39% | 25.46% | -100.00% | nan% | nan% | |||
| Operating expenses | 31.448 M | 27.146 M | 14.940 M | 9.154 M | 10.066 M | 9.240 M | |
| Selling general and admin | 26.982 M | 22.673 M | 9.549 M | 5.831 M | 6.030 M | 4.962 M | |
| Research and development | 4.466 M | 4.473 M | 5.391 M | 3.323 M | 4.036 M | 4.278 M | |
| Total expenses | 33.274 M | 28.131 M | 14.894 M | 9.587 M | 9.836 M | 9.240 M | |
| -15.46% | -47.05% | -35.63% | 2.60% | -6.06% | |||
| Operating income | -31.902 M | -26.031 M | -14.474 M | -9.587 M | -9.836 M | -9.240 M | |
| Ebit | -31.902 M | -26.031 M | -14.474 M | -9.587 M | -9.836 M | -9.240 M | |
| Pretax income | -32.941 M | -28.111 M | 29.073 M | -12.843 M | -14.455 M | -10.413 M | |
| -14.66% | -203.42% | -144.18% | 12.55% | -27.96% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -32.941 M | -28.111 M | 29.073 M | -12.843 M | -14.455 M | -10.413 M | |
| 14.66% | 203.42% | -144.18% | -12.55% | 27.96% | |||
| Net income | -32.941 M | -28.111 M | 29.073 M | -12.843 M | -14.455 M | -10.413 M | |
| 14.66% | 203.42% | -144.18% | -12.55% | 27.96% |